STOCK TITAN

Medtronic to announce financial results for its fourth quarter and full fiscal year 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Medtronic plc (NYSE:MDT) will announce its financial results for the fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. The company will release summary financial information for the period ending on Friday, April 26, 2024. The results will be discussed in a video webcast at 7:00 a.m. CDT on the same day, with a replay and transcript available within 24 hours. Medtronic plans to report fiscal year 2025 results on various dates later in the year.

Positive
  • None.
Negative
  • None.

Insights

The upcoming financial results announcement for Medtronic's fourth quarter and full fiscal year 2024 is a pivotal moment for existing and potential stakeholders. Historically, this period has been critical, as it provides insights into the company's performance and can significantly move its stock price. A critical evaluation of these results will hinge on several key indicators. Firstly, revenue trends are paramount; investors should monitor for both year-over-year and sequential growth, which signal the company's ability to expand its market presence and manage cyclicality. Additionally, earnings per share (EPS) will be scrutinized for profitability and operational efficiency. Margins also come under the spotlight; improvements here could indicate success in cost management or product mix shifts towards higher-margin offerings. Lastly, forward-looking statements and guidance give a glimpse into management's confidence and strategic direction. These elements will be particularly vital given the backdrop of an ever-evolving healthcare landscape.

Beyond the numbers, Medtronic's report will be assessed for strategic developments within its diverse portfolio of medical technologies. As healthcare continues to emphasize personalized and cost-effective care, investors should observe any advancements or setbacks in high-growth areas like surgical robotics and insulin pumps. Any mention of regulatory hurdles, successful approvals, or progress in clinical trials could also sway sentiment. The strategic narrative in their earnings call, including how Medtronic plans to tackle prevalent health issues and competitive pressures, will be instrumental in evaluating their long-term positioning. Additionally, the report's reflection on market penetration and expansion, particularly in emerging markets, will provide important context for the company's growth trajectory.

DUBLIN, May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.

Medtronic will host a video webcast at 7:00 a.m. CDT on Thursday, May 23, 2024, to discuss results for its fourth quarter and full fiscal year 2024. The webcast can be accessed at https://investorrelations.medtronic.com.

Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.

Looking ahead, Medtronic plans to report its first, second, third, and fourth quarter fiscal year 2025 results on Tuesday, August 20, 2024, Tuesday, November 19, 2024, Tuesday, February 18, 2025, and Thursday, May 22, 2025, respectively. For these events, confirmation and additional details will be provided closer to the specific event.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:




Erika Winkels

 Ryan Weispfenning

Public Relations

Investor Relations

+1-763-526-8478

+1-763-505-4626

 

(PRNewsfoto/Medtronic plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-fourth-quarter-and-full-fiscal-year-2024-302140511.html

SOURCE Medtronic plc

FAQ

When will Medtronic announce its financial results for the fourth quarter and full fiscal year 2024?

Medtronic will announce its financial results for the fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024.

Where can I access the news release with the summary financial information for Medtronic's fourth quarter and full fiscal year 2024?

The news release will be available at https://news.medtronic.com.

What time will the video webcast discussing Medtronic's fourth quarter and full fiscal year 2024 results start?

The webcast will start at 7:00 a.m. CDT on Thursday, May 23, 2024.

When will Medtronic report its first, second, third, and fourth quarter fiscal year 2025 results?

Medtronic plans to report its fiscal year 2025 results on Tuesday, August 20, 2024, Tuesday, November 19, 2024, Tuesday, February 18, 2025, and Thursday, May 22, 2025, respectively.

Medtronic plc

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Stock Data

109.12B
1.28B
0.26%
85.42%
0.79%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
DUBLIN